ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Environmental Emphasis Urged, Including New Role For Comp Centers NCAB Unenthusiastic

March 21, 1975

Consensus Conference Suggest Research Required For Advances In Pain Control

May 30, 1986

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

NCCS Networker Volume 2 Issue 3, Summer 1988

June 13, 1988

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Reviews of the Faculty Report by Irwin Krakoff, Robert Cook-Deegan, and Michael Katz

March 29, 2013